BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/22/2021 10:34:53 AM | Browse: 344 | Download: 598
 |
Received |
|
2021-07-11 20:09 |
|
Peer-Review Started |
|
2021-07-11 20:12 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-07-26 03:34 |
|
Revised |
|
2021-08-08 21:24 |
|
Second Decision |
|
2021-09-08 03:00 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-09-08 09:55 |
|
Articles in Press |
|
2021-09-08 09:55 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-09-18 10:17 |
|
Typeset the Manuscript |
|
2021-11-15 02:01 |
|
Publish the Manuscript Online |
|
2021-11-22 10:34 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Case Report |
| Article Title |
Heart failure as an adverse effect of infliximab for Crohn's disease: A case report and review of literature
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Thais Gagno Grillo, Luciana Rocha Almeida, Rodrigo Fedatto Beraldo, Mariana Barros Marcondes, Diego Aparecido Rios Queiróz, Daniel Luiz da Silva, Rodrigo Quera, Julio Pinheiro Baima, Rogerio Saad-Hossne and Ligia Yukie Sassaki |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Thais Gagno Grillo, MD, Medical Assistant, Department of Internal Medicine, São Paulo State University (Unesp), Medical School, Av. Prof. Mário Rubens Guimarães Montenegro, s/n, Botucatu 18618687, São Paulo, Brazil. thaisgagno@gmail.com |
| Key Words |
Heart failure; Infliximab; Anti-tumor necrosis factor therapy; Crohn's disease; Inflammatory bowel disease; Case report |
| Core Tip |
Anti-tumor necrosis factor agents were the first biologic therapy approved for the management of Crohn's disease (CD). While rare, heart failure (HF) is a potential adverse effect of these medications. In this report we described a patient with CD who developed HF after treatment with infliximab. The clinical, diagnosis, imaging, and treatment details are all provided and discussed in this case report. This reported case supports the need to investigate risk factors for HF and to consider the risk-benefit of introducing infliximab therapy in patients presenting with HF risk factors and inflammatory bowel disease. |
| Publish Date |
2021-11-22 10:34 |
| Citation |
Grillo TG, Almeida LR, Beraldo RF, Marcondes MB, Queiróz DAR, da Silva DL, Quera R, Baima JP, Saad-Hossne R, Sassaki LY. Heart failure as an adverse effect of infliximab for Crohn's disease: A case report and review of literature. World J Clin Cases 2021; 9(33): 10382-10391 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i33/10382.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i33.10382 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
